TrialAnnals of the American Thoracic Society2020

Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial.

Terri E Weaver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.